Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Essential role of an ERV-derived Env38 protein in adaptive humoral immunity against an exogenous SVCV infection in a zebrafish model. | PLoS Pathog | 2023 | 37014912 | PubTator, text mining | PubMed |
| Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer. | Aging (Albany NY) | 2023 | 37014322 | PubTator, text mining | PubMed |
| Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis. | BMC Cancer | 2023 | 37013511 | PubTator, text mining | PubMed |
| Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours. | Front Immunol | 2023 | 37006256 | PubTator, text mining | PubMed |
| BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma. | Front Immunol | 2023 | 37006240 | PubTator, text mining | PubMed |
| T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis. | Front Immunol | 2023 | 36993982 | PubTator, text mining | PubMed |
| Past, Present, and a Glance into the Future of Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2023 | 36986514 | PubTator, text mining | PubMed |
| The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies. | Cancers (Basel) | 2023 | 36980798 | PubTator, text mining | PubMed |
| Upregulation of Sarcolemmal Hemichannels and Inflammatory Transcripts with Neuromuscular Junction Instability during Lower Limb Unloading in Humans. | Biology (Basel) | 2023 | 36979123 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies. | Biomark Res | 2023 | 36978204 | PubTator, text mining | PubMed |
| Exosomes: New regulators of reproductive development. | Mater Today Bio | 2023 | 36969697 | PubTator, text mining | PubMed |
| Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. | Front Immunol | 2023 | 36969169 | PubTator, text mining | PubMed |
| LSD1 inhibition modulates transcription factor networks in myeloid malignancies. | Front Oncol | 2023 | 36969082 | PubTator, text mining | PubMed |
| Exploring the immunological role and prognostic potential of PPM1M in pan-cancer. | Medicine (Baltimore) | 2023 | 36961170 | PubTator, text mining | PubMed |
| SERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma. | BMC Urol | 2023 | 36959648 | PubTator, text mining | PubMed |
| Adherent-invasive Escherichia coli associated with granulomatous colitis and extraintestinal dissemination in a Sphynx cat. | Vet Pathol | 2023 | 36951102 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in Recurrent Multiple Infection Including Live Attenuated Virus Vaccine. | J Clin Immunol | 2023 | 36947335 | PubTator, text mining | PubMed |
| Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson's disease. | J Neuroinflammation | 2023 | 36945016 | PubTator, text mining | PubMed |
| Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. | BMC Bioinformatics | 2023 | 36935487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=24